These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 35456671)

  • 1. Recent Advances in the Treatment of Alzheimer's Disease Using Nanoparticle-Based Drug Delivery Systems.
    Poudel P; Park S
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer's Disease.
    Jain U; Johari S; Srivastava P
    Mol Neurobiol; 2024 Apr; 61(4):1969-1989. PubMed ID: 37831361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
    Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
    Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
    Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
    Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations.
    Bukhari SNA
    Curr Drug Deliv; 2022; 19(1):17-31. PubMed ID: 34514990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
    Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomaterials in treatment of Alzheimer's disease.
    Agrawal M; Prathyusha E; Ahmed H; Dubey SK; Kesharwani P; Singhvi G; Naidu VGM; Alexander A
    Neurochem Int; 2021 May; 145():105008. PubMed ID: 33684545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanoparticles: A promising strategy for treatment of Alzheimer's disease.
    Elmahboub YSM; Elkordy AA
    J Taibah Univ Med Sci; 2024 Jun; 19(3):549-565. PubMed ID: 38736898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review.
    Jalili C; Kiani A; Gholami M; Bahrehmand F; Fakhri S; Kakehbaraei S; Kakebaraei S
    IET Nanobiotechnol; 2023 May; 17(3):154-170. PubMed ID: 36949020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotheranostic agents for neurodegenerative diseases.
    Padmanabhan P; Palanivel M; Kumar A; Máthé D; Radda GK; Lim KL; Gulyás B
    Emerg Top Life Sci; 2020 Dec; 4(6):645-675. PubMed ID: 33320185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of Nanoparticles in Alzheimer's Disease.
    Liu Y; Shen Y
    J Alzheimers Dis; 2023; 96(2):459-471. PubMed ID: 37807779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology.
    Hersh AM; Alomari S; Tyler BM
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke and Age-related Neurodegenerative Diseases.
    Farhoudi M; Sadigh-Eteghad S; Mahmoudi J; Farjami A; Mahmoudian M; Salatin S
    Curr Pharm Des; 2022; 28(24):1985-2000. PubMed ID: 35676838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies/systems.
    Roghani AK; Garcia RI; Roghani A; Reddy A; Khemka S; Reddy RP; Pattoor V; Jacob M; Reddy PH; Sehar U
    Ageing Res Rev; 2024 Jun; 97():102291. PubMed ID: 38614367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.
    Saraiva C; Praça C; Ferreira R; Santos T; Ferreira L; Bernardino L
    J Control Release; 2016 Aug; 235():34-47. PubMed ID: 27208862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics.
    Hettiarachchi SD; Zhou Y; Seven E; Lakshmana MK; Kaushik AK; Chand HS; Leblanc RM
    J Control Release; 2019 Nov; 314():125-140. PubMed ID: 31647979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in developing therapeutic strategies for Alzheimer's disease.
    Nguyen TT; Nguyen TTD; Nguyen TKO; Vo TK; Vo VG
    Biomed Pharmacother; 2021 Jul; 139():111623. PubMed ID: 33915504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and its treatment by different approaches: A review.
    Srivastava S; Ahmad R; Khare SK
    Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer's Disease Therapeutics and Diagnostics.
    de la Torre C; Ceña V
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30336640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer's disease.
    Muolokwu CE; Chaulagain B; Gothwal A; Mahanta AK; Tagoe B; Lamsal B; Singh J
    Front Pharmacol; 2024; 15():1405423. PubMed ID: 38855744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.